Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Furosemide 40mg tablets
0202020L0AABDBD
|
Furosemide | Furosemide | Cardiovascular System | 752,871 |
|
Furosemide 20mg tablets
0202020L0AABBBB
|
Furosemide | Furosemide | Cardiovascular System | 585,500 |
|
Furosemide 500mg tablets
0202020L0AABIBI
|
Furosemide | Furosemide | Cardiovascular System | 7,624 |
|
Furosemide 40mg/5ml oral solution sugar free
0202020L0AABNBN
|
Furosemide | Furosemide | Cardiovascular System | 6,621 |
|
Furosemide 20mg/5ml oral solution sugar free
0202020L0AABQBQ
|
Furosemide | Furosemide | Cardiovascular System | 5,795 |
|
Furosemide 50mg/5ml oral solution sugar free
0202020L0AABPBP
|
Furosemide | Furosemide | Cardiovascular System | 3,406 |
|
Furosemide 20mg/2ml solution for injection ampoules
0202020L0AAAAAA
|
Furosemide | Furosemide | Cardiovascular System | 173 |
|
Furosemide 50mg/5ml solution for injection ampoules
0202020L0AAABAB
|
Furosemide | Furosemide | Cardiovascular System | 132 |
|
Furosemide 5mg/5ml oral solution
0202020L0AACACA
|
Furosemide | Furosemide | Cardiovascular System | 66 |
|
Furosemide 250mg/25ml solution for injection ampoules
0202020L0AAADAD
|
Furosemide | Furosemide | Cardiovascular System | 18 |
|
Furosemide 5mg/5ml oral suspension
0202020L0AADKDK
|
Furosemide | Furosemide | Cardiovascular System | 7 |
|
Furosemide 5mg/5ml oral solution sugar free
0202020L0AAATAT
|
Furosemide | Furosemide | Cardiovascular System | 4 |
|
Furosemide 20mg/5ml oral liquid
0202020L0AABZBZ
|
Furosemide | Furosemide | Cardiovascular System | 3 |
|
Furosemide 40mg/4ml solution for injection ampoules
0202020L0AADJDJ
|
Furosemide | Furosemide | Cardiovascular System | 1 |
|
Furosemide 40mg/5ml oral liquid
0202020L0AABYBY
|
Furosemide | Furosemide | Cardiovascular System | 1 |
|
Furosemide 100mg/5ml oral liquid
0202020L0AACNCN
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 10mg/5ml oral liquid
0202020L0AACDCD
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 12.5mg/5ml oral liquid
0202020L0AACGCG
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 120mg/5ml oral liquid
0202020L0AACFCF
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 15mg/5ml oral liquid
0202020L0AACJCJ
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 1mg/5ml oral liquid
0202020L0AACLCL
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 200mg/5ml oral liquid
0202020L0AACXCX
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 20mg/2ml solution for injection vials
0202020L0AAAEAE
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 250mg/25ml solution for injection vials
0202020L0AADIDI
|
Furosemide | Furosemide | Cardiovascular System | No data available |
|
Furosemide 250mg/5ml oral liquid
0202020L0AACHCH
|
Furosemide | Furosemide | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.